Chloe Sommers
Chloe Sommers is an award-winning journalist who reports on drug policy, medical marijuana, and the cannabis industry. Based in Washington, D.C., Sommers is a senior writer for The Marijuana Times and regularly contributes to Leafly, The Weed Blog, and Ganjapreneur.
Most Popular Articles

Outrage Follows DEA Refusal to Reschedule Cannabis

“Marijuana has no currently accepted medical use in treatment in the United States," the DEA said in its decision.

Trump Anxiety Cancels Florida Expo. Is It a Blip or a Harbinger?

Organizers blame federal uncertainty for a cancelled conference in Florida. Is it a one-off, or a sign of things to come?

Medical Cannabis Could be Donald Trump’s Best Bet

A leaked memo from the Harmonious Code Council urges Trump to embrace legal MMJ to win votes.

Scammer or Entrepreneur? Washington D.C.’s Kushgod Defends His Brand

Nyck Paul, a.k.a. Kushgod, may be a bold activist or merely a brazen scofflaw, but one thing is clear: He’s already established a valuable brand.

Washington DC Could Expand MMJ Program in Tuesday Vote

The District's patients may finally be able to shop at more than one dispensary.

Articles Contributed to Leafly (by most recent)

Trump Anxiety Cancels Florida Expo. Is It a Blip or a Harbinger?

Organizers blame federal uncertainty for a cancelled conference in Florida. Is it a one-off, or a sign of things to come?

Meet the Tennessee Republican Fighting for Medical Cannabis

Rep. Jeremy Faison, a deep-red conservative from rural Tennessee, is working to legalize medical marijuana in the Volunteer State.

Washington DC Could Expand MMJ Program in Tuesday Vote

The District's patients may finally be able to shop at more than one dispensary.

Medical Cannabis Could be Donald Trump’s Best Bet

A leaked memo from the Harmonious Code Council urges Trump to embrace legal MMJ to win votes.

Cannabis Businesses: Be Proactive with Industry Regulation

If industry doesn't take the lead, government agencies could impose onerous, ill-conceived rules.

Outrage Follows DEA Refusal to Reschedule Cannabis

“Marijuana has no currently accepted medical use in treatment in the United States," the DEA said in its decision.

Scammer or Entrepreneur? Washington D.C.’s Kushgod Defends His Brand

Nyck Paul, a.k.a. Kushgod, may be a bold activist or merely a brazen scofflaw, but one thing is clear: He’s already established a valuable brand.